CervoMed, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison

Sell

41

CRVO
CervoMed, Inc.

Last Price:

$4.12

Seasonality Move:

-6.19%

Sell

17

NONOF
Novo Nordisk A/S

Last Price:

$35.59

Seasonality Move:

4.8%

Sell

41

CervoMed, Inc. (CRVO) is a Sell

Is CervoMed, Inc. a Buy, Sell or Hold?

The current CervoMed, Inc. [CRVO] share price is $4.14. The Score for CRVO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
CRVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

17

Novo Nordisk A/S (NONOF) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

CRVO Stock Price Chart

What is CervoMed, Inc.'s stock price today?

The CervoMed, Inc. share price today is $4.14

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVO is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk A/S's stock price today?

The Novo Nordisk A/S share price today is $35.59

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.

CRVO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.22	Sell
Relative Strength Index (14 RSI):	47.2	Sell
Chaikin Money Flow:	-5780	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.85 - 4.39)	Buy
Bollinger Bands (100):	(4.46 - 8.24)	Sell

NONOF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.13	Sell
Relative Strength Index (14 RSI):	34	Sell
Chaikin Money Flow:	-84014	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(35.94 - 38.44)	Sell
Bollinger Bands (100):	(39.64 - 55.38)	Sell

CRVO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.91	Buy
20-day SMA:	4.16	Sell
50-day SMA:	4.6	Sell
200-day SMA:	7.25	Sell
8-day EMA:	3.98	Buy
20-day EMA:	4.13	Buy
50-day EMA:	4.81	Sell
200-day EMA:	6.78	Sell

NONOF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35.83	Sell
20-day SMA:	37	Sell
50-day SMA:	44.15	Sell
200-day SMA:	53.01	Sell
8-day EMA:	35.83	Sell
20-day EMA:	37.34	Sell
50-day EMA:	41.96	Sell
200-day EMA:	54.32	Sell

CervoMed, Inc. Earnings Growth & CRVO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.05 per share, an increase this year of $0.42 per share, and an increase next year of $0.69 per share.

Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CervoMed, Inc. Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):